Pfizer, Takeda Units End Antitrust Case Over Protonix Patent

Law360, New York (July 17, 2013, 6:01 PM ET) -- A New Jersey federal court on Monday signed off on an agreement dismissing putative class antitrust allegations that Pfizer Inc.'s Wyeth and Takeda Pharmaceutical Co. Ltd.'s Altana Pharma AG fraudulently obtained a patent related to the acid reflux drug Protonix.

U.S. District Judge Jose L. Linares approved a stipulation of dismissal in a proposed antitrust class action brought against Wyeth and Altana. The suit alleged that Altana secured a patent on Protonix through fraud and, in turn, used that invalid patent to file sham infringement allegations...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required